[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355210-105":59,"doc-detail-355210-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","smyd3-synergises-with-rack1-to-promote-colorectal-cancer-lung-metastasis-by-recruiting-smad3","SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3","","Cancer metastasis drives mortality in colorectal cancer (CRC), and clinical outcome depends largely on whether metastasis emerges during disease progression. Integrated bioinformatics of mRNA expression and epigenetic modifiers identified SMYD3 as a top differential histone modifier in CRC. SMYD3 overexpression correlates with poor prognosis and increased metastatic ability. Immunoprecipitation-mass spectrometry uncovered RACK1 as a novel SMYD3 partner, enabling SMYD3 to recruit SMAD3 via RACK1-mediated scaffolding to activate TSKU transcription.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/smyd3-synergises-with-rack1-to-promote-colorectal-cancer-lung-metastasis-by-recruiting-smad3/355210/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/smyd3-synergises-with-rack1-to-promote-colorectal-cancer-lung-metastasis-by-recruiting-smad3/355210.png","ImageObject",300,407,{"name":92,"@type":93},"Riley","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was identified as a key epigenetic factor in colorectal cancer?","Question",{"text":112,"@type":113},"The study identified SMYD3 as the top differential ly expressed histone modifier in CRC through integrated bioinformatics analysis of mRNA expression profiles and epigenetic modifiers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were RACK1 and SMAD3 connected to the SMYD3 pathway?",{"text":117,"@type":113},"Immunoprecipitation-mass spectrometry discovered RACK1 as a novel SMYD3-interacting protein, and mechanistic work showed that SMYD3 recruits SMAD3 through RACK1-mediated scaffolding.",{"name":119,"@type":110,"acceptedAnswer":120},"Why might targeting the SMYD3-SMAD3 interaction be therapeutically relevant?",{"text":121,"@type":113},"RACK1 depletion disrupts SMYD3–SMAD3 complex formation, and the SMYD3-SMAD3 transcriptional axis is described as critical for metastasis regulation, suggesting that inhibiting their interaction could help treat CRC metastasis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355210,1790240509,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Bai etal. Cell Communication and Signaling (2026) 24:156  \n[https://doi.org/10.1186/s12964-026-02687-5](https://doi.org/10.1186/s12964-026-02687-5)  \nCell Communication and Signaling  \nRESEARCH Open Access  \nSMYD3 synergises with RACK1 to promote  colorectal cancer lung metastasis by recruiting SMAD3  \nXiaoming Bai 1†, Dong Han2†, Jie Chen2†, Siqi Sheng2, Haimei Feng 1, Hongyu Wang 1, Ke Xu2, Yadi Huang4, Mengxi Huang2*, Xiaoyuan Chu 1,2,3,4*, Yitian Chen 1,2* and Zengjie Lei 1,2,3,4*  \nAbstract  \nCancer metastasis is the leading cause of mortality associated with cancer, and the prognosis for patients diagnosed with colorectal cancer(CRC) largely depends on the occurrence of metastasis during the progression of the disease. A comprehensive understanding of the mechanisms underlying metastasis in CRC is essential for advancing treatment strategies. Through integrated bioinformatics analysis of mRNA expression profiles and epigenetic modifiers, we identified SMYD3 as the top differential ly expressed histone modifier in CRC. Clinically, SMYD3 overexpression significantly associates with poor prognosis and enhances metastatic potential. Utilizing immunoprecipitation-mass spectrometry, we discovered RACK1 as a novel SMYD3-interacting protein. Subsequent mechanistic studies revealed a tripartite interaction network: SMYD3 recruits SMAD3 through RACK1-mediated scaffolding, facilitating transcriptional activation of the downstream effector TSKU. Notably, RACK1 depletion disrupts SMYD3-SMAD3 complex formation, establishing the critical role of this axis in metastasis regulation. Consequently, inhibiting the SMYD3-SMAD3 interaction may represent a promising therapeutic strategy for addressing CRC metastasis. In conclusion, targeting the SMYD3-RACK1-SMAD3 transcriptional complex presents a viable approach for the treatment of CRC metastasis.  \nKeywords Colorectal cancer, Metastasis, SMYD3, RACK1, SMAD3  \n†Xiaoming Bai, Dong Han and Jie Chen contributed equally to this work.  \n*Correspondence: Mengxi Huang  \nhuangmengxi [1@163.com](1@163.com)  \nXiaoyuan Chu[chuxiaoyuan000@163.com](chuxiaoyuan000@163.com)[ ](chuxiaoyuan000@163.com)Yitian Chen [yitianchen@126.com](yitianchen@126.com)[ ](yitianchen@126.com)Zengjie Lei [leizengjie@163.com](leizengjie@163.com)  \n1Jinling Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China  \n2Department of Medical Oncology, Nanjing Jinling Hospital, Affiliated Hospital of Medical School, Nanjing University, 305 Zhongshan East Road, Xuanwu District, Nanjing, Jiangsu Province 210000, China 3Department of Medical Oncology, Jinling Hospital, Nanjing Medical University, Nanjing, Jiangsu Province, China  \n4Department of Medical Oncology, Jinling Hospital, The First School of Clinical Medicine, Southern Medical University, Nanjing, Jiangsu Province, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creativecommons.org/l)icenses/by/4.0/.  \nBai et al. Cell Communication and Signaling (2026) 24:156  \nIntroduction  \nColorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancerrelated mortality globally [1]. Current first-line treatments h","cbCaifM2EIExil9k","https://ap.wps.com/l/cbCaifM2EIExil9k","pdf",15798947,"English","# Abstract\n# Introduction\n## Colorectal cancer burden and unmet prognosis\n## Epigenetic hallmarks and histone modification enzymes\n## SMYD family and SMYD3 in CRC\n## RACK1 as a scaffolding protein","[{\"question\":\"What was identified as a key epigenetic factor in colorectal cancer?\",\"answer\":\"The study identified SMYD3 as the top differential ly expressed histone modifier in CRC through integrated bioinformatics analysis of mRNA expression profiles and epigenetic modifiers.\"},{\"question\":\"How were RACK1 and SMAD3 connected to the SMYD3 pathway?\",\"answer\":\"Immunoprecipitation-mass spectrometry discovered RACK1 as a novel SMYD3-interacting protein, and mechanistic work showed that SMYD3 recruits SMAD3 through RACK1-mediated scaffolding.\"},{\"question\":\"Why might targeting the SMYD3-SMAD3 interaction be therapeutically relevant?\",\"answer\":\"RACK1 depletion disrupts SMYD3–SMAD3 complex formation, and the SMYD3-SMAD3 transcriptional axis is described as critical for metastasis regulation, suggesting that inhibiting their interaction could help treat CRC metastasis.\"}]","SMYD3 synergises with RACK1 to promote colorectal cancer lung metastasis by recruiting SMAD3 | PDF",1790116750,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e6fa3289536ddab688bc22d7d960bb46.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52f487faac263c8c1637904dfbc78359.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/edddfa98ea380699c04e8ffe537c4ef2.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/057ff26b5d9beae82941f4b1bb3b6b42.webp",980,1306]